Last reviewed · How we verify
vaginal progesterone suppositories — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
vaginal progesterone suppositories (vaginal progesterone suppositories) — Toronto Centre for Advanced Reproductive Technology.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| vaginal progesterone suppositories TARGET | vaginal progesterone suppositories | Toronto Centre for Advanced Reproductive Technology | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- vaginal progesterone suppositories CI watch — RSS
- vaginal progesterone suppositories CI watch — Atom
- vaginal progesterone suppositories CI watch — JSON
- vaginal progesterone suppositories alone — RSS
Cite this brief
Drug Landscape (2026). vaginal progesterone suppositories — Competitive Intelligence Brief. https://druglandscape.com/ci/vaginal-progesterone-suppositories. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing